Clinical Research Directory
Browse clinical research sites, groups, and studies.
Substance Use in Pregnant People - Optimizing Retention in Treatment
Sponsor: Washington University School of Medicine
Summary
Substance use during pregnancy is a leading cause of maternal morbidity and mortality in the United States, with 55-80% of postpartum patients disengaging from substance use disorder (SUD) treatment within one year of delivery. Structural and social determinants of health, including housing instability, transportation barriers, and limited childcare access, further exacerbate disparities in treatment retention. This pilot study, conducted in two specialized prenatal care clinics, evaluates the feasibility and acceptability of two integrated strategies to promote sustained engagement in recovery-oriented services during the perinatal and postpartum periods. Aim 1 implements a standardized social needs screening and referral protocol to connect patients with community-based supports. Aim 2 pilots a contingency management intervention to incentivize recovery-supportive behaviors. Findings will inform the design of a larger multi-site randomized controlled trial to evaluate the impact of these interventions on treatment retention, overdose prevention, and maternal-infant health outcomes.
Official title: Substance Use in Pregnant People - Optimizing Retention in Treatment by Maximizing Opportunities for Management
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-02-02
Completion Date
2026-08
Last Updated
2026-02-04
Healthy Volunteers
No
Interventions
Social drivers of health screening
Patients will undergo a structured and protocoled screening for social drivers of health and be linked to support services
Patients will undergo a program of contingency management
Patients will enter into a 12 week program of contingency management
Locations (2)
University of Maryland
Baltimore, Maryland, United States
Washington University
St Louis, Missouri, United States